Biezonski, D
Shah, R
Krivko, A
Cha, J
Guilfoyle, D N
Hrabe, J
Gerum, S
Xie, S
Duan, Y
Bansal, R
Leventhal, B L
Peterson, B S
Kellendonk, C
Posner, J
Article History
Received: 2 March 2016
Revised: 29 June 2016
Accepted: 16 July 2016
First Online: 6 September 2016
Competing interests
: Shire Pharmaceuticals kindly provided lisdexamfetamine dimesylate for this study (CK). JP has received research support from Shire Pharmaceuticals for examining the effects of LDX on humans in a separate study. The findings and conclusions of this study are those of the investigators and are not supported by Shire. The remaining authors declare no conflict of interest.